β-Blockers and refractory ascites in cirrhosis: The message of a team of true scientists
Author:
Publisher
Elsevier BV
Subject
Hepatology
Reference20 articles.
1. Propranolol: a medical treatment for portal hypertension;Lebrec;Lancet,1980
2. Propranolol for prevention of gastrointestinal bleeding in patients with cirrhosis. A controlled study;Lebrec;N Engl J Med,1981
3. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension;De Franchis;J Hepatol,2010
4. An evidence-based medicine approach to β-blocker therapy in patients with cirrhosis;Talwalkar;Am J Med,2004
5. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model;Saab;Am. J. Gastroenterol.,2003
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. NON-SELECTIVE BETA-BLOCKERS IN CIRRHOTIC PATIENTS WITH REFRACTORY ASCITES: WHERE ARE WE?;Arquivos de Gastroenterologia;2024
2. Cardiac dysfunction in patients with cirrhosis;European Journal of Gastroenterology & Hepatology;2015-06
3. Beta-blockers in cirrhosis and refractory ascites: a retrospective cohort study and review of the literature;Scandinavian Journal of Gastroenterology;2014-08-12
4. Zolmitriptan: A Novel Portal Hypotensive Agent Which Synergizes with Propranolol in Lowering Portal Pressure;PLoS ONE;2013-01-16
5. Improving Survival in Decompensated Cirrhosis;International Journal of Hepatology;2012
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3